Taniguchi, Daisuke
Kamata, Satoshi
Rostami, Sara
Tuin, Stephen
Marin-Araujo, Alba
Guthrie, Kelly
Petersen, Thomas
Waddell, Thomas K.
Karoubi, Golnaz
Keshavjee, Shaf
Haykal, Siba
Funding for this research was provided by:
United Therapeutics Corporation (Funding number: 410012492)
Article History
Received: 29 May 2023
Accepted: 28 November 2023
First Online: 8 December 2023
Competing interests
: Funding from United Therapeutics was provided to S.Ke., T.K.W., G.K. and S.H. in order to conduct the studies (Funding number: 410012492). This supportive and non-biased funding did not affect outcome/conclusions of the research. S.T., K.G. and T.P. are employees of and own stock in United Therapeutics. The rest of the authors (D.T., S.Ka., S.R., A.M-A.) have no conflict of interest.